GSK-3 Inhibitors and Tooth Repair: An Ethical Analysis

GSK-3 Inhibitors and Tooth Repair: An Ethical Analysis

Tideglusib®, a GSK-3 inhibitor, was initially tested for the treatment of Alzheimer’s disease. However, a recent report has suggested its potential off-label use for the treatment of dental cavities. Even if this effect is not yet confirmed, this off-label use can have significant public/dental heal...

Full description

Bibliographic Details
Main Authors: Sorin Hostiuc, Paula Perlea, Mihai Marinescu, Catalin Dogaroiu, Eduard Drima
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-01-01
Series:Frontiers in Pharmacology
Subjects:
Tideglusib
Alzheimer’s disease
dental cavities
stem cells
non-maleficence
autonomy
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2018.01495/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2018.01495/full

Similar Items